Development of a method to detect very low levels of HER2 expression in Circulating Tumor Cells (CTCs) by liquid biopsy in patients with metastatic breast cancer

被引：0
|
作者：
Di Caro, Giuseppe
Bourdon, David
Kunihiro, Andrew
Cunsolo, Alessandra
Lam, Ernest
Slade, Megan
Blankfard, Martin
Schwartzberg, Lee
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-04-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-04-04
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Expression of truncated HER2 receptor in circulating tumor cells (CTCs) of breast cancer patients
    Kallergi, Galaktia
    Nasias, Dimitris
    Papadaki, Maria A.
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Agelaki, Sophia
    CANCER RESEARCH, 2012, 72
  • [2] Truncated HER2 receptor in circulating tumor cells (CTCs) of early and metastatic breast cancer patients
    Kallergi, G.
    Nasias, D.
    Papadaki, M.
    Mavroudis, D.
    Georgoulias, V.
    Agelaki, S.
    CANCER RESEARCH, 2012, 72
  • [3] Prospective Evaluation of Serum HER2 and HER2 Expression on Circulating Tumor Cells in Patients with Metastatic Breast Cancer within the DETECT Study
    Mueller, V
    Riethdorf, S.
    Rack, B.
    Janni, W.
    Fasching, P.
    Pantel, K.
    Gebauser, G.
    Solomayer, E.
    Aktas, B.
    Kasemier-Bauer, S.
    Fehm, T.
    CANCER RESEARCH, 2009, 69 (24) : 662S - 662S
  • [4] Increased chromatin heterogeneity in circulating tumor cells (CTCs) is associated with high levels of HER2 expression in metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorenzo
    Shah, Ami N.
    Davis, Andrew Adam
    Flaum, Lisa
    Zhou, Xiang
    Zhang, Youbin
    Backman, Vadim
    Behdad, Amir
    Wehbe, Firas
    Gradishar, William
    Platanias, Leonidas
    Cristofanilli, Massimo
    CANCER RESEARCH, 2019, 79 (13)
  • [5] FLUCTUATION OF HER2/NEU PROTEIN LEVELS IN CIRCULATING TUMOR CELLS (CTCS) FROM METASTATIC BREAST CANCER (MBC) PATIENTS (PTS)
    Bessi, S.
    Galardi, F.
    Truglia, M. C.
    Pestrin, M.
    Chiarelli, C.
    Cappadona, S.
    Licitra, S.
    Biganzoli, L.
    Giannini, A.
    ANNALS OF ONCOLOGY, 2009, 20 : 50 - 50
  • [6] Prospective evaluation of serum HER2 in comparison with HER2 expression on circulating tumor cells in metastatic breast cancer patients as part of the DETECT study
    Mueller, V.
    Riethdorf, S.
    Rack, B.
    Janni, W.
    Fasching, P.
    Gebauer, G.
    Solomayer, E.
    Aktas, B.
    Zeitz, J.
    Kasimir-Bauer, S.
    Fehm, T.
    ONKOLOGIE, 2010, 33 : 19 - 19
  • [7] HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)
    Ontiveros, Priscilla
    Landaverde, Connie
    Levin, Maren K.
    Hippely, Sarah
    Landers, Mark
    Wang, Yipeng
    Dittamore, Ryan
    O'Shaughnessy, Joyce A.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Expression of CCR5 associated with HER2 in circulating tumor cells (CTCs) is a novel biomarker for patients with metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorezo
    Shah, Ami N.
    Davis, Andrew A.
    Flaum, Lisa
    Zhang, Youbin
    Pestell, Richard G.
    Wehbe, Firas
    Behdad, Amir
    Platanias, Leonidas
    Gradishar, William
    Cristofanilli, Massimo
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Enabling HER2 and androgen receptor (AR) protein expression and localization in circulating tumor cells (CTCs) of ER(+/-)HER2(-) metastatic breast cancer (MBC) patients (pts)
    Ontiveros, P.
    Landaverde, C.
    Graf, R.
    Levin, M. K.
    Hippely, S.
    Wang, Y.
    Landers, M.
    Dittamore, R.
    O'Shaughnessy, J. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Circulating tumor cells (CTCs) detect HER2+status and phenotypic heterogeneity in metastatic breast cancer (MBC)
    Austin, Laura
    Mu, Zhaomei
    Avery, Tiffany
    Jaslow, Rebecca
    Paolillo, Carmela
    Toss, Angela
    Fortuna, Paolo
    Zhong, Ye
    Yang, Hushan
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75
12345